What Everyone Must Know About Neurorehabilitation Market size was valued at $ 1,097.69 million in 2020 and IS projected to reach $ 2,451.25 million by 2030 registering a CAGR OF of 8.3% TO 2030.

Bionik Laboratories Corp., BioScience Managers Ltd (Rex Bionics Ltd), Bioventus (Bioness Inc.), DIH (Hocoma AG), Ekso Bionics Holdings, Inc., Eodyne, Neofect, Neuro Rehab VR, Reha Technology AG, ReWalk Robotics Ltd.

The neurorehabilitation market can be segmented by application into several areas, including:

1. Stroke: This segment includes products and services for the rehabilitation of individuals who have had a stroke, such as physical therapy equipment, speech therapy services, and rehabilitation software.
2. Traumatic Brain Injury (TBI): This segment includes products and services for the rehabilitation of individuals who have had a TBI, such as physical therapy equipment, occupational therapy equipment, and rehabilitation software.
3. Spinal Cord Injury (SCI): This segment includes products and services for the rehabilitation of individuals who have had a SCI, such as exoskeletons, functional electrical stimulation (FES) systems, and rehabilitation software.
4. Parkinson’s Disease: This segment includes products and services for the rehabilitation of individuals with Parkinson’s disease, such as physical therapy equipment, occupational therapy equipment, and rehabilitation software.
5. Multiple Sclerosis (MS): This segment includes products and services for the rehabilitation of individuals with MS, such as physical therapy equipment, occupational therapy equipment, and rehabilitation software.
6. Others: This segment includes products and services for the rehabilitation of individuals with other neurological conditions such as Cerebral Palsy, Huntington’s disease, Amyotrophic lateral sclerosis (ALS) and others.

The global neurorehabilitation market can also be segmented by region

1. North America: This region includes the United States and Canada, and is expected to hold a significant share of the global neurorehabilitation market due to the presence of a large number of players in the market, high healthcare expenditure, and the presence of a large number of patients with neurological conditions.
2. Europe: This region includes countries such as Germany, the United Kingdom, France, and Spain. Europe is expected to hold a significant share of the global neurorehabilitation market due to the presence of a large number of patients with neurological conditions and the presence of a large number of players in the market.
3. Asia-Pacific: This region includes countries such as China, Japan, India, and Australia. The Asia-Pacific region is expected to witness significant growth in the neurorehabilitation market due to the increasing aging population, rising incidence of neurological disorders, and the increasing healthcare expenditure.
4. LAMEA: This region includes countries such as Latin America, Middle East, and Africa. LAMEA is expected to witness moderate growth in the neurorehabilitation market due to the presence of a large number of patients with neurological conditions, and the increasing healthcare expenditure in these regions.

Speak With Analyst : https://www.alliedmarketresearch.com/connect-to-analyst/10826

Some possible end users include:

1. Rehabilitation Centers: This segment includes products and services used in specialized rehabilitation centers that focus on treating patients with neurological conditions. These centers often provide a range of therapies and treatments, including physical therapy, occupational therapy, and speech therapy.
2. Hospitals: This segment includes products and services used in general hospitals for the rehabilitation of patients with neurological conditions. Patients may receive therapy as part of their inpatient or outpatient care.
3. Clinics: This segment includes products and services used in specialized clinics that focus on treating patients with neurological conditions. These clinics often provide a specific type of therapy or treatment, such as physical therapy or speech therapy.

Neurorehabilitation market can also be segmented by type

1. Neuro-Robotic Devices: This segment includes robotic exoskeletons, upper limb rehabilitation robots, and other devices that use robotic technology to aid in the rehabilitation of patients with neurological conditions. These devices can be used for tasks such as gait training, upper limb movement training, and balance training.
2. Non-Invasive Stimulators: This segment includes devices that use non-invasive methods to stimulate the brain, such as functional electrical stimulation (FES) systems and transcranial magnetic stimulation (TMS) devices. These devices can be used for tasks such as muscle stimulation, pain management, and motor control training.
3. Brain-Computer Interfaces: This segment includes devices that use brain-computer interface technology to enable communication between a patient and a computer. These devices can be used for tasks such as cursor control, speech generation, and other forms of communication.